Reginald Seeto - Feb 28, 2022 Form 4 Insider Report for CareDx, Inc. (CDNA)

Role
President and Chief Executive Officer, Director
Signature
/s/ Reginald Seeto
Stock symbol
CDNA
Transactions as of
Feb 28, 2022
Transactions value $
-$234,860
Form type
4
Date filed
3/1/2022, 07:49 PM
Previous filing
Feb 10, 2022
Next filing
Mar 23, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDNA Common Stock Award $0 +6.1K +3.21% $0.00 196K Feb 28, 2022 Direct F1
transaction CDNA Common Stock Tax liability -$113K -2.95K -1.5% $38.38 193K Feb 28, 2022 Direct F2
transaction CDNA Common Stock Sale -$122K -3.15K -1.63% $38.62 190K Mar 1, 2022 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported securities were represented by restricted performance stock units that were granted on November 2, 2020, 100% of which vested on February 28, 2022 upon the achievement of the requisite performance criteria.
F2 These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units.
F3 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.30 to $39.07, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares sold at each separate price.

Remarks:

President and Chief Executive Officer